These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26366793)

  • 1. Erbium laser in gynecology.
    Vizintin Z; Lukac M; Kazic M; Tettamanti M
    Climacteric; 2015; 18 Suppl 1():4-8. PubMed ID: 26366793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erbium laser in gynecology: aims, aspirations and action points.
    Gambacciani M; Cervigni M
    Climacteric; 2015; 18 Suppl 1():2-3. PubMed ID: 26366792
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
    Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
    Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
    Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary outcome of non-ablative vaginal Erbium laser treatment for female stress and mixed urinary incontinence.
    Su CF; Chen GD; Tsai HJ
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):610-613. PubMed ID: 31542080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.
    Mothes AR; Runnebaum M; Runnebaum IB
    J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence.
    Giarenis I; Tsiapakidou S; Zacche M; Mukhopadhyay S; Mahmood T
    Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():342-344. PubMed ID: 38811292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M
    Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser therapy for the restoration of vaginal function.
    Gambacciani M; Palacios S
    Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.
    Shobeiri SA; Kerkhof MH; Minassian VA; Bazi T;
    Int Urogynecol J; 2019 Mar; 30(3):371-376. PubMed ID: 30523374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Cervigni M
    Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years.
    Gambacciani M; Cervigni M; Gaspar A; Novakov Mikić A; Gaviria J; Koron N; Vizintin Z
    Climacteric; 2020; 23(sup1):S28-S32. PubMed ID: 33124457
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of intraurethral Erbium:YAG laser treatment in women with stress urinary incontinence following failed intravaginal laser therapy: a retrospective study.
    Tseng YL; Su CF
    Lasers Med Sci; 2023 Sep; 38(1):207. PubMed ID: 37688606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial.
    Blaganje M; Šćepanović D; Žgur L; Verdenik I; Pajk F; Lukanović A
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():153-158. PubMed ID: 29604548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Erbium: Yttrium-Aluminum-Garnet Laser Treatment in Chinese Women with Mild-to-Moderate Stress Urinary Incontinence.
    Tan Y; Zhang Y; An J; Xu X; Deng J; Chen B; Pan W
    J Womens Health (Larchmt); 2024 May; 33(5):685-691. PubMed ID: 38563974
    [No Abstract]   [Full Text] [Related]  

  • 18. Erbium:YAG laser treatment of female stress urinary incontinence: midterm data.
    Kuszka A; Gamper M; Walser C; Kociszewski J; Viereck V
    Int Urogynecol J; 2020 Sep; 31(9):1859-1866. PubMed ID: 31828400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Er:YAG Laser for Women with Stress Urinary Incontinence.
    Lin KL; Chou SH; Long CY
    Biomed Res Int; 2019; 2019():7915813. PubMed ID: 30766886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study.
    Fistonić N; Fistonić I; Lukanovič A; Findri Guštek Š; Sorta Bilajac Turina I; Franić D
    Climacteric; 2015; 18 Suppl 1():37-42. PubMed ID: 26366799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.